RMTI

Rockwell Medical Inc. Common Stock (RMTI)

Stock · NASDAQ · Health Care

$7.37as of 10/16/2026

AI Market Commentary

AI-generatedAll commentary →

Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.

October 8, 2026

Rockwell Medical Ranked 16th on Fortune Best Workplaces List. Rockwell Medical was named the 16th best workplace in manufacturing and production on Fortune's 2026 list. This recognition highlights the company's internal culture and employee satisfaction. While not a direct financial metric, such rankings can support long-term talent retention and brand reputation.

Price chart

Open in TradingView

Active signals

Support Reject53.5%
High Beta35.7%
Revenue-Price Divergence (6M)31.9%200 SMA Touch0.0%
Resistance level
$7.81
Industry
Biotechnology: Pharmaceutical Preparations

RMTI Signal Track Record

How signals performed across all stocks →

What RMTI's price did in the 20 trading sessions after each past signal, compared with any 20-session window over the same period.

SignalTimesMedian 20-session returnHigher after 20 sessions
Volume Spike35-4.0%40%
Bollinger Band Breakout26-6.6%42%
Bollinger Band Breakdown16-6.5%31%
200-Day Moving Average TouchActive now10-2.1%50%
Any 20-session window (baseline)-3.6%44%

Computed by MarketWall from daily closing prices since May 18, 2022. Returns are close-to-close and don't include dividends. Past results describe what happened before; they are not a forecast and not investment advice.

About RMTI

Rockwell Medical, Inc., together with its subsidiaries, engages in the development, manufacture, commercialization, and distribution of various hemodialysis products for dialysis providers worldwide. It offers citrapure citric acid concentrate, dri-sate dry acid concentrate, renalpure liquid acid concentrate, dri-sate acid concentrate mixer, renalpure acid concentrate, renalpure bicarbonate concentrate, sterilyte bic…

Sector
Health Care
Industry
Biotechnology: Pharmaceutical Preparations
Employees
157

Fundamentals

1-day range
$7.24$7.97
Market cap
$28.26M
P/E (trailing)
—
P/E (forward)
106.14
EPS (trailing)
$-1.33
Dividend yield
—
Beta
1.70
Avg. volume
28.1K
52-week range
$4.89$12.9
Next earnings: November 12, 2026 · EPS estimate $-0.18confirmed

How Rockwell Medical Inc. Common Stock Makes Money

Where the revenue actually goes — FY2025 annual results

market-wall.comTotalRevenue$69.26MCost of Revenue$57.56M (83%)SG&A$16.39M (24%)RMTI

Source: 10-K filed Mar 26, 2026 · via SEC EDGAR / Finnhub

Gross Profit$11.70M(17%)
Operating Income-$4.69M(-7%)

Forecasts

2 analyst ratings

Buy 88%
Hold 13%
Sell 0%
1-year price forecast
High
$20
+171.4%
Median
$20
+171.4%
Low
$20
+171.4%

Rockwell Medical Inc. Common Stock Competitors

Chosen by industry and closest market cap.

  • RMTI
    Rockwell Medical Inc. Common Stock
    $7.43
    ▼ 6.89%
    Market cap $28.26MP/E —
    $4.89$12.9
  • KYNB
    Kyntra Bio Inc. Common Stock
    $4.85
    ▼ 9.51%
    Market cap $28.26MP/E 0.12
    $5.34$11.65
  • GRCE
    Grace Therapeutics Inc. Common Stock
    $1.89
    ▼ 3.08%
    Market cap $28.44MP/E —
    $1.79$5.18
  • MIRA
    MIRA Pharmaceuticals Inc. Common Stock
    $0.632
    ▼ 3.95%
    Market cap $28.50MP/E —
    $0.6$2.45
  • ACTU
    Actuate Therapeutics Inc. Common stock
    $0.605
    ▲ 21.00%
    Market cap $29.43MP/E —
    $0.41$8.27
  • ABVC
    ABVC BioPharma Inc. Common Stock
    $0.918
    ▼ 1.61%
    Market cap $27.09MP/E —
    $0.7069$3.07
  • BCTX
    BriaCell Therapeutics Corp. Common Shares
    $3.4
    ▼ 9.81%
    Market cap $30.01MP/E —
    $3.68$20.4

P/E shows — for peers not currently carrying a live signal of their own.

Latest news

Insider Activity

Insider Actions →
Acquired
138.2K
Disposed
1.0K

See the full, filterable feed with live charts on the MarketWall dashboard.

We use analytics to understand how market-wall is used. No personal data is sold.